Implementation of the S'TIM Serious-Game for Rehabilitation of Dysexecutive Disorders (S'TIM) (S'TIM 1)

November 5, 2021 updated by: Ramsay Générale de Santé

Implementation of the S'TIM Serious-Game for Rehabilitation of Dysexecutive Disorders

This study proposes to improve the management of dysexecutive syndrome by a serious game (SG) in addition to the usual management including work in occupational therapy and neuropsychology.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aubagne, France, 13400
        • Recruiting
        • Clinique de Provence Bourbonne
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • French-speaking male or female patient at least 18 years old
  • Patient suffering from recent disorders (less than 6 months) of executive functions
  • Patient with sufficient mobility of the upper limb (mobility of the dominant upper limb greater than 70 °) to interact with the device.
  • Patient affiliated or beneficiary of a social security scheme
  • Patient having signed the free and informed consent.

Exclusion Criteria:

  • Patient participating in another clinical study
  • Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision,
  • Pregnant or breastfeeding woman,
  • Patient hospitalized without consent.
  • Patient with unstable psychiatric disorders
  • Patient with comprehension disorders (alexia, visual agnosia, illiteracy, not understanding the language, etc.)
  • Patient with executive function disorders greater than 6 months
  • Negligent hemi patient
  • Patient not familiar with the French language
  • Patient with major neuro-visual disorders.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Patients with Serious Game
Video Game S'tim : the patient is inside a bedroom and he has to find a friend outside. this game will study the orientation, the memory of the patient
NO_INTERVENTION: Patients without Serious Game

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The effect of using the serious-game S'TIM in terms of cognition
Time Frame: 6 weeks
TAP sub-test ERFC : overall cognitive functions BREF : presence or absence of a cognitive and / or behavioral dysexecutive syndrome
6 weeks
The effect of using the serious-game S'TIM at 6 weeks in terms of metacognition with the BRIEF-A
Time Frame: 6 weeks
Behaviour Rating Inventory of Executive Function, Adult
6 weeks
The effect of using the serious-game S'TIM at 6 weeks in terms of behavior with BRIEF-A
Time Frame: 6 weeks
Behaviour Rating Inventory of Executive Function, Adult
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 3, 2020

Primary Completion (ANTICIPATED)

December 3, 2021

Study Completion (ANTICIPATED)

June 3, 2022

Study Registration Dates

First Submitted

November 5, 2021

First Submitted That Met QC Criteria

November 5, 2021

First Posted (ACTUAL)

November 17, 2021

Study Record Updates

Last Update Posted (ACTUAL)

November 17, 2021

Last Update Submitted That Met QC Criteria

November 5, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 2019-A00244-53

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Serious Game

Clinical Trials on Serious Game S'TIM

3
Subscribe